Eltrombopag for Thrombocytopenia in Patients With Relapsed Multiple Myeloma

Categoría Estudio primario
Registro de estudiosclinicaltrials.gov
Año 2012
Cargando información sobre las referencias
Eltrombopag is a compound that may help stimulate the production of platelets. This drug has been used in treatment of low platelet counts caused by a disorder called idiopathic thrombocytopenic purpura and information from those other research studies suggests that Eltrombopag may help to maintain platelet counts in patients with relapsed multiple myeloma in this research study.

In this research study,the investigators are trying to determine if Eltrombopag is effective in maintaining platelet counts in patients who are being treated for relapsed multiple myeloma.
Epistemonikos ID: 5f0e0fed9827463d22289b39369831129e3cb3dd
First added on: May 10, 2024